1. A predictive survival model for patients with head and neck squamous cell carcinoma treated with immune check point inhibitors. (November 2020) Authors: Bonomi, M.; Bhateja, P.; Issa, M.; Klamer, B.; Pan, X.; Blakaj, A.; Karivedu, V.; Mousa, L.; Mitchell, D.; Gamez, M; Kang, S.; Seim, Nolan B.; Old, M.; Carrau, R.; Rocco, J.; Blakaj, D. Journal: Oral oncology Issue: Volume 110(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. In vitro and in vivo activity of "compound A" against gram-positive and -negative pathogens including MDR strains. (April 2016) Authors: Burman, T.K.; Bhateja, P.; Dube, S.; Soni, A. Journal: International journal of infectious diseases Issue: Volume 45(2016:Apr.)Supplement 1 Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗